We are live on ! Find out more
YARW

Yarrow Bioscience, Inc. Common Stock
YARW

98 hedge funds and large institutions have $138M invested in Yarrow Bioscience, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 33 increasing their positions, 21 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 21

1% more funds holding

Funds holding: 97 → 98 (+1)

6% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 16

5% more capital invested

Capital invested by funds: $132M → $138M (+$6.25M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% more ownership

Funds ownership: 0.01% → 0.01% (+0%)

Holders
98
Holders Change
+1
Holders Change %
+1.03%
% of All Funds
1.73%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
17
Increased
33
Reduced
21
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$3.74M
2
DAM
Deltec Asset Management
New York
+$3.66M
3
Two Sigma Investments
Two Sigma Investments
New York
+$1.05M
4
Squarepoint
Squarepoint
New York
+$873K
5
State Street
State Street
Massachusetts
+$867K

Top Sellers

Rank Fund Capital Flow
1
VC
Vivo Capital
California
-$1.54M
2
MIM
Monashee Investment Management
Massachusetts
-$581K
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$352K
4
Morgan Stanley
Morgan Stanley
New York
-$276K
5
SSA
Schonfeld Strategic Advisors
New York
-$258K
Name Holding Trade Value Shares
Change 		Change in
Stake
Commonwealth Equity Services
51
Commonwealth Equity Services
Massachusetts
$122K -$50.3K -8 -28%
SSA
52
Schonfeld Strategic Advisors
New York
$119K -$258K -41 -66%
VF
53
Virtu Financial
New York
$105K -$107K -17 -49%
VOYA Investment Management
54
VOYA Investment Management
Georgia
$105K +$31.4K +5 +38%
Ohio Public Employees Retirement System (OPERS)
55
Ohio Public Employees Retirement System (OPERS)
Ohio
$105K +$107K +17 +1,700%
FIM
56
Fernwood Investment Management
Massachusetts
$97K -$31.4K -5 -23%
ProShare Advisors
57
ProShare Advisors
Maryland
$92K +$69.1K +11 +220%
RJA
58
Raymond James & Associates
Florida
$86K – – –
State Board of Administration of Florida Retirement System
59
State Board of Administration of Florida Retirement System
Florida
$79K – – –
SCA
60
STALEY CAPITAL ADVISERS
Pennsylvania
$79K +$88K +14 New
BPA
61
Beacon Pointe Advisors
California
$72K -$12.6K -2 -13%
CS
62
Credit Suisse
Switzerland
$69K +$56.6K +9 +300%
JGC
63
J. Goldman & Co
New York
$64K – – –
NAM
64
Nexpoint Asset Management
Texas
$64K – – –
Dimensional Fund Advisors
65
Dimensional Fund Advisors
Texas
$57K -$6.28K -1 -9%
SG Americas Securities
66
SG Americas Securities
New York
$55K +$62.8K +10 New
Susquehanna International Group
67
Susquehanna International Group
Pennsylvania
$54K +$6.28K +1 +13%
TRCT
68
Tower Research Capital (TRC)
New York
$53K -$151K -24 -73%
LNWWM
69
Laird Norton Wetherby Wealth Management
California
$52K – – –
Citigroup
70
Citigroup
New York
$52K +$44K +7 +350%
Verition Fund Management
71
Verition Fund Management
Connecticut
$40K – – –
CSS
72
Cubist Systematic Strategies
Connecticut
$40K +$31.4K +5 +250%
FHC
73
Fort Henry Capital
West Virginia
$39K +$44K +7 New
Invesco
74
Invesco
Georgia
$39K +$44K +7 New
Bank of Montreal
75
Bank of Montreal
Ontario, Canada
$37K +$25.1K +4 +200%
1 2
3
4 5

YARW Hedge Fund Activity: Q4 2020 in Review

98 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Yarrow Bioscience, Inc. Common Stock (YARW) for Q4 2020, worth a combined $138M — up 4.7% from $132M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new YARW positions and 16 closed out — a net gain of 1 holder — while 33 added to existing stakes and 21 trimmed.

The largest buyer was BlackRock, adding an estimated $3.74M. The largest seller was Vivo Capital, cutting an estimated $1.54M.

  • 98 institutional investors held Yarrow Bioscience, Inc. Common Stock (YARW) as of Q4 2020, up from 97 in Q3 2020.
  • Funds reported $138M of Yarrow Bioscience, Inc. Common Stock stock for Q4 2020, up 4.7% quarter-over-quarter.
  • 17 funds opened new Yarrow Bioscience, Inc. Common Stock positions in Q4 2020 and 16 closed out, a net change of +1 holder.
  • The largest Yarrow Bioscience, Inc. Common Stock buyer in Q4 2020 was BlackRock, an estimated $3.74M added.
  • The largest Yarrow Bioscience, Inc. Common Stock seller in Q4 2020 was Vivo Capital, an estimated $1.54M sold.

Based on aggregated 13F filings for Q4 2020.